| Identification | Back Directory | [Name]
1,2,5-Oxadiazol-3-amine, 4-[1-(4-pyridinylmethyl)-1H-benzimidazol-2-yl]- | [CAS]
361368-24-3 | [Synonyms]
C 101248
KCNK13-IN-1
3-amino-4-[1-(pyridin-4-ylmethyl)-1H-benzimidazol-2-yl]-furazan
1,2,5-Oxadiazol-3-amine, 4-[1-(4-pyridinylmethyl)-1H-benzimidazol-2-yl]- | [Molecular Formula]
C15H12N6O | [MOL File]
361368-24-3.mol | [Molecular Weight]
292.3 |
| Chemical Properties | Back Directory | [Boiling point ]
594.2±60.0 °C(Predicted) | [density ]
1.51±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
5.36±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
KCNK13-IN-1 (example 71), a KCNK13 antagonist, is an anti-inflammatory agent, with an IC50 of <200 nM for IL-1 β[1]. | [References]
[1] Roland BüRLI, et al. Novel compounds. Patent WO2022167819. |
|
|